Liyile Chen1, Qiuru Wang1, Donghai Li1, Changjun Chen1, Qianhao Li1, Pengde Kang2. 1. Department of Orthopaedics Surgery, West China Hospital, Sichuan University, 37# Wainan Guoxue Road, Chengdu, 610041, People's Republic of China. 2. Department of Orthopaedics Surgery, West China Hospital, Sichuan University, 37# Wainan Guoxue Road, Chengdu, 610041, People's Republic of China. kangpengd@163.com.
Abstract
BACKGROUND: Opioid use is prevalent in the general population. This systematic review and meta-analysis sought to evaluate whether it affects patient-reported outcomes (PROs) following total hip or knee arthroplasty. METHODS: The following databases were systematically searched on February 5, 2020: Medline, Embase (Ovid), Cochrane Library, and Web of Science. Studies were included if they compared patients who received opioids or not before total hip or knee arthroplasty. Outcomes of interest were rates of post-operative revision, peri-prosthetic infection, and readmission. RESULTS: Ten retrospective studies were included for review. Pre-operative opioid use was identified as a risk factor for post-operative revision [odds ratio (OR) 1.58, 95% confidence interval (CI) 1.15-1.73, p<0.01], peri-prosthetic infection (OR 1.36, 95% CI 1.08-1.71, p=0.01), and readmission (OR 1.41, 95% CI 1.20-1.75, p<0.01). CONCLUSION: The available evidence indicates that pre-operative opioid use increases the risk of adverse outcomes following total hip or knee arthroplasty. Orthopedic physicians should consider these risks when treating their patients.
BACKGROUND: Opioid use is prevalent in the general population. This systematic review and meta-analysis sought to evaluate whether it affects patient-reported outcomes (PROs) following total hip or knee arthroplasty. METHODS: The following databases were systematically searched on February 5, 2020: Medline, Embase (Ovid), Cochrane Library, and Web of Science. Studies were included if they compared patients who received opioids or not before total hip or knee arthroplasty. Outcomes of interest were rates of post-operative revision, peri-prosthetic infection, and readmission. RESULTS: Ten retrospective studies were included for review. Pre-operative opioid use was identified as a risk factor for post-operative revision [odds ratio (OR) 1.58, 95% confidence interval (CI) 1.15-1.73, p<0.01], peri-prosthetic infection (OR 1.36, 95% CI 1.08-1.71, p=0.01), and readmission (OR 1.41, 95% CI 1.20-1.75, p<0.01). CONCLUSION: The available evidence indicates that pre-operative opioid use increases the risk of adverse outcomes following total hip or knee arthroplasty. Orthopedic physicians should consider these risks when treating their patients.
Authors: Michael G Zywiel; D Alex Stroh; Seung Yong Lee; Peter M Bonutti; Michael A Mont Journal: J Bone Joint Surg Am Date: 2011-11-02 Impact factor: 5.284
Authors: Kelvin Kim; Kevin K Chen; Mackenzie Roof; Afshin A Anoushiravani; Jonathan Vigdorchik; Ran Schwarzkopf Journal: J Clin Orthop Trauma Date: 2019-04-30
Authors: Jenna Goesling; Stephanie E Moser; Bilal Zaidi; Afton L Hassett; Paul Hilliard; Brian Hallstrom; Daniel J Clauw; Chad M Brummett Journal: Pain Date: 2016-06 Impact factor: 7.926
Authors: C Michael Goplen; Wesley Verbeek; Sung Hyun Kang; C Allyson Jones; Donald C Voaklander; Thomas A Churchill; Lauren A Beaupre Journal: BMC Musculoskelet Disord Date: 2019-05-18 Impact factor: 2.362
Authors: Che Suraya Zin; Nor Ilyani Nazar; Norny Syafinaz Rahman; Nor Elina Alias; Wan Rohaidah Ahmad; Nurul Sahida Rani; Mary Suma Cardosa; Kim Swan Ng; Felicia Loh Ye Journal: J Pain Res Date: 2018-09-20 Impact factor: 3.133
Authors: Johan Simonsson; Erik Bülow; Karin Svensson Malchau; Fredrik Nyberg; Urban Berg; Ola Rolfson Journal: Acta Orthop Date: 2022-01-03 Impact factor: 3.717